U.S. markets closed
  • S&P Futures

    4,550.25
    +5.75 (+0.13%)
     
  • Dow Futures

    35,429.00
    +40.00 (+0.11%)
     
  • Nasdaq Futures

    15,607.00
    +19.75 (+0.13%)
     
  • Russell 2000 Futures

    2,254.40
    +4.90 (+0.22%)
     
  • Crude Oil

    80.81
    -1.85 (-2.24%)
     
  • Gold

    1,803.20
    +4.40 (+0.24%)
     
  • Silver

    24.14
    -0.05 (-0.21%)
     
  • EUR/USD

    1.1610
    +0.0004 (+0.03%)
     
  • 10-Yr Bond

    1.5290
    -0.0900 (-5.56%)
     
  • Vix

    16.98
    +1.00 (+6.26%)
     
  • GBP/USD

    1.3741
    -0.0001 (-0.01%)
     
  • USD/JPY

    113.6200
    -0.1900 (-0.17%)
     
  • BTC-USD

    58,979.45
    -1,455.00 (-2.41%)
     
  • CMC Crypto 200

    1,414.53
    -59.80 (-4.06%)
     
  • FTSE 100

    7,253.27
    -24.35 (-0.33%)
     
  • Nikkei 225

    28,825.62
    -272.62 (-0.94%)
     

Moore Kuehn, PLLC Encourages Investors of OCGN to Contact Law Firm

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

New York, New York--(Newsfile Corp. - August 12, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:

  • Ocugen, Inc. (NASDAQ: OCGN)

The company or its officers and directors made materially false and misleading statements and/or failed to disclose that: (1) the information submitted to the FDA was insufficient to support an EUA; (2) the Company would not file an Emergency Use Authorization with the FDA; (3) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about the Company's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

If you own OCGN please contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245. There is no cost to you. Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers.

Please visit http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/

Attorney advertising. Prior results do not guarantee similar outcomes.

Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com
(212) 709-8245

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/92997